🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The safety and tolerability of MK-8591A, a 2-drug fixed dose combination (F...
Status
Active Not Recruiting
Location
Pueblo Family Physicians ( Site 0010)
Start Date
2021-09-15
Trial ID
NCT04776252
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Active Not Recruiting
Location
Kaiser Permanente-Infectious Disease ( Site 3014)
Start Date
2023-02-20
Trial ID
NCT05631093
This study will evaluate the safety and efficacy of a switch to MK-8591A (a...
Status
Completed
Location
Georgetown University Hospital ( Site 1018)
Start Date
2020-02-18
Trial ID
NCT04223778
This study will evaluate the safety and efficacy of a switch to Doravirine/...
Status
Completed
Location
Pueblo Family Physicians ( Site 2717)
Start Date
2020-02-18
Trial ID
NCT04223791
Treatments Being Tested
This is a randomized, active-controlled, double-blind clinical study design...
Status
Active Not Recruiting
Location
Pueblo Family Physicians ( Site 5674)
Start Date
2023-03-08
Trial ID
NCT05705349
Treatments Being Tested
This is a phase 2, single-group, multi-site, open-label study of an islatra...
Status
Completed
Location
Children's National Medical Center ( Site 1816)
Start Date
2020-11-26
Trial ID
NCT04295772
Treatments Being Tested
The goal of this study is to learn what happens to doravirine (DOR) and isl...
Status
Completed
Location
QPS Missouri ( Site 0001)
Start Date
2025-09-26
Trial ID
NCT07086079
Treatments Being Tested
The primary objectives of this study are to evaluate the antiretroviral act...
Status
Active Not Recruiting
Location
Pueblo Family Physicians ( Site 1425)
Start Date
2023-02-17
Trial ID
NCT05630755
Treatments Being Tested
This study will evaluate the safety, tolerability, antiretroviral activity,...
Status
Completed
Location
Pueblo Family Physicians ( Site 0119)
Start Date
2017-11-27
Trial ID
NCT03272347
The purpose of this study is to learn what happens to MK-8591A in a person'...
Status
Completed
Location
Celerion (Site 0001)
Start Date
2024-01-23
Trial ID
NCT06719570
Treatments Being Tested